Literature DB >> 24753537

Inherited biallelic CSF3R mutations in severe congenital neutropenia.

Alexa Triot1, Päivi M Järvinen1, Juan I Arostegui2, Dhaarini Murugan1, Naschla Kohistani1, José Luis Dapena Díaz3, Tomas Racek1, Jacek Puchałka1, E Michael Gertz4, Alejandro A Schäffer4, Daniel Kotlarz1, Dietmar Pfeifer5, Cristina Díaz de Heredia Rubio3, Mehmet Akif Ozdemir6, Turkan Patiroglu6, Musa Karakukcu6, José Sánchez de Toledo Codina3, Jordi Yagüe2, Ivo P Touw7, Ekrem Unal6, Christoph Klein1.   

Abstract

Severe congenital neutropenia (SCN) is characterized by low numbers of peripheral neutrophil granulocytes and a predisposition to life-threatening bacterial infections. We describe a novel genetic SCN type in 2 unrelated families associated with recessively inherited loss-of-function mutations in CSF3R, encoding the granulocyte colony-stimulating factor (G-CSF) receptor. Family A, with 3 affected children, carried a homozygous missense mutation (NM_000760.3:c.922C>T, NP_000751.1:p.Arg308Cys), which resulted in perturbed N-glycosylation and aberrant localization to the cell surface. Family B, with 1 affected infant, carried compound heterozygous deletions provoking frameshifts and premature stop codons (NM_000760.3:c.948_963del, NP_000751.1:p.Gly316fsTer322 and NM_000760.3:c.1245del, NP_000751.1:p.Gly415fsTer432). Despite peripheral SCN, all patients had morphologic evidence of full myeloid cell maturation in bone marrow. None of the patients responded to treatment with recombinant human G-CSF. Our study highlights the genetic and morphologic SCN variability and provides evidence both for functional importance and redundancy of G-CSF receptor-mediated signaling in human granulopoiesis.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24753537      PMCID: PMC4055927          DOI: 10.1182/blood-2013-11-535419

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia.

Authors:  K Devriendt; A S Kim; G Mathijs; S G Frints; M Schwartz; J J Van Den Oord; G E Verhoef; M A Boogaerts; J P Fryns; D You; M K Rosen; P Vandenberghe
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

2.  Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.

Authors:  M Horwitz; K F Benson; R E Person; A G Aprikyan; D C Dale
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

3.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

4.  Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.

Authors:  Richard E Person; Feng-Qian Li; Zhijun Duan; Kathleen F Benson; Jeremy Wechsler; Helen A Papadaki; George Eliopoulos; Christina Kaufman; Salvatore J Bertolone; Betty Nakamoto; Thalia Papayannopoulou; H Leighton Grimes; Marshall Horwitz
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

5.  The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.

Authors:  S T Sawyer; W D Hankins
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

6.  Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia.

Authors:  F Dong; L H Hoefsloot; A M Schelen; C A Broeders; Y Meijer; A J Veerman; I P Touw; B Löwenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Deletional mutation of the external domain of the human granulocyte colony-stimulating factor receptor in a patient with severe chronic neutropenia refractory to granulocyte colony-stimulating factor.

Authors:  Srish Sinha; Quan Sheng Zhu; Guillermo Romero; Seth J Corey
Journal:  J Pediatr Hematol Oncol       Date:  2003-10       Impact factor: 1.289

8.  Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers.

Authors:  G S Chatta; T H Price; R C Allen; D C Dale
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

9.  Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.

Authors:  G J Lieschke; D Grail; G Hodgson; D Metcalf; E Stanley; C Cheers; K J Fowler; S Basu; Y F Zhan; A R Dunn
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

10.  Mutations in SPAG1 cause primary ciliary dyskinesia associated with defective outer and inner dynein arms.

Authors:  Michael R Knowles; Lawrence E Ostrowski; Niki T Loges; Toby Hurd; Margaret W Leigh; Lu Huang; Whitney E Wolf; Johnny L Carson; Milan J Hazucha; Weining Yin; Stephanie D Davis; Sharon D Dell; Thomas W Ferkol; Scott D Sagel; Kenneth N Olivier; Charlotte Jahnke; Heike Olbrich; Claudius Werner; Johanna Raidt; Julia Wallmeier; Petra Pennekamp; Gerard W Dougherty; Rim Hjeij; Heon Yung Gee; Edgar A Otto; Jan Halbritter; Moumita Chaki; Katrina A Diaz; Daniela A Braun; Jonathan D Porath; Markus Schueler; György Baktai; Matthias Griese; Emily H Turner; Alexandra P Lewis; Michael J Bamshad; Deborah A Nickerson; Friedhelm Hildebrandt; Jay Shendure; Heymut Omran; Maimoona A Zariwala
Journal:  Am J Hum Genet       Date:  2013-09-19       Impact factor: 11.025

View more
  14 in total

Review 1.  Severe congenital neutropenias.

Authors:  Julia Skokowa; David C Dale; Ivo P Touw; Cornelia Zeidler; Karl Welte
Journal:  Nat Rev Dis Primers       Date:  2017-06-08       Impact factor: 52.329

2.  Validation is a dish oft served cold.

Authors:  David B Wilson
Journal:  Blood       Date:  2014-06-12       Impact factor: 22.113

3.  Old and new faces of neutropenia in children.

Authors:  Carlo Dufour; Maurizio Miano; Francesca Fioredda
Journal:  Haematologica       Date:  2016-07       Impact factor: 9.941

Review 4.  Cytokine receptor splice variants in hematologic diseases.

Authors:  Borwyn Wang; Hrishikesh Mehta
Journal:  Cytokine       Date:  2019-12-06       Impact factor: 3.861

Review 5.  New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Authors:  Seth J Corey; Usua Oyarbide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.

Authors:  Haijiao Zhang; Sophie Means; Anna Reister Schultz; Kevin Watanabe-Smith; Bruno C Medeiros; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Tim Kükenshöner; Oliver Hantschel; Jeffrey W Tyner
Journal:  Cancer Res       Date:  2017-06-26       Impact factor: 12.701

Review 7.  Children with rare diseases of neutrophil granulocytes: from therapeutic orphans to pioneers of individualized medicine.

Authors:  Christoph Klein
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

8.  Zebrafish Granulocyte Colony-Stimulating Factor Receptor Maintains Neutrophil Number and Function throughout the Life Span.

Authors:  Faiza Basheer; Parisa Rasighaemi; Clifford Liongue; Alister C Ward
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

Review 9.  Lessons learned from the study of human inborn errors of innate immunity.

Authors:  Giorgia Bucciol; Leen Moens; Barbara Bosch; Xavier Bossuyt; Jean-Laurent Casanova; Anne Puel; Isabelle Meyts
Journal:  J Allergy Clin Immunol       Date:  2018-08-01       Impact factor: 10.793

10.  Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.

Authors:  Amy M Trottier; Lawrence J Druhan; Ira L Kraft; Amanda Lance; Simone Feurstein; Maria Helgeson; Jeremy P Segal; Soma Das; Belinda R Avalos; Lucy A Godley
Journal:  Blood Adv       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.